{"title":"丁丙诺啡在怀孕期间改善母亲和新生儿的健康","authors":"Alison Knopf","doi":"10.1002/adaw.34539","DOIUrl":null,"url":null,"abstract":"<p>Opioid use disorder (OUD) in pregnancy is a serious problem, but buprenorphine and methadone, medications which treat the disorder, both improve outcomes for mothers and their children. Researchers conducted a retrospective cohort study of Medicaid Tennessee pregnant patients, and found buprenorphine compared to no treatment improved outcomes. For the study, “Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes,” published in <i>JAMA Health Forum</i> April 27, the researchers followed 14,463 maternal-infant dyads continuously enrolled in the Tennessee Medicaid program from 20 weeks' estimated gestational age to 6 weeks post-partum between 2010 and 2021.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":"4-6"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Buprenorphine in pregnancy improves health of mom and newborn\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/adaw.34539\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Opioid use disorder (OUD) in pregnancy is a serious problem, but buprenorphine and methadone, medications which treat the disorder, both improve outcomes for mothers and their children. Researchers conducted a retrospective cohort study of Medicaid Tennessee pregnant patients, and found buprenorphine compared to no treatment improved outcomes. For the study, “Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes,” published in <i>JAMA Health Forum</i> April 27, the researchers followed 14,463 maternal-infant dyads continuously enrolled in the Tennessee Medicaid program from 20 weeks' estimated gestational age to 6 weeks post-partum between 2010 and 2021.</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"37 22\",\"pages\":\"4-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34539\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34539","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Buprenorphine in pregnancy improves health of mom and newborn
Opioid use disorder (OUD) in pregnancy is a serious problem, but buprenorphine and methadone, medications which treat the disorder, both improve outcomes for mothers and their children. Researchers conducted a retrospective cohort study of Medicaid Tennessee pregnant patients, and found buprenorphine compared to no treatment improved outcomes. For the study, “Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes,” published in JAMA Health Forum April 27, the researchers followed 14,463 maternal-infant dyads continuously enrolled in the Tennessee Medicaid program from 20 weeks' estimated gestational age to 6 weeks post-partum between 2010 and 2021.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
